Disease | intrahepatic cholangiocarcinoma |
Phenotype | C0153452|gallbladder cancer |
Sentences | 1 |
PubMedID- 26022204 | Another possible explanation could involve the higher rate of kras mutations seen in intrahepatic cholangiocarcinomas as compared with gallbladder cancers, possibly mediating resistance to upstream her2 blockade [2, 5, 36]. |
Page: 1